These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7886775)

  • 1. Multiresistant falciparum malaria cured using atovaquone and proguanil.
    Blanchard TJ; Mabey DC; Hunt-Cooke A; Edwards G; Hutchinson DB; Benjamin S; Chiodini PL
    Trans R Soc Trop Med Hyg; 1994; 88(6):693. PubMed ID: 7886775
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimalaria activity of the triple combination of proguanil, atovaquone and dapsone.
    Yeo AE; Edstein MD; Rieckmann KH
    Acta Trop; 1997 Sep; 67(3):207-14. PubMed ID: 9241385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone/proguanil for plasmodium falciparum malaria.
    Sehdev PS
    Pediatr Infect Dis J; 2002 Aug; 21(8):787-9. PubMed ID: 12192170
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of malarone in therapy of malaria tropica].
    Ziegler T; Schau A; Winkler C
    Med Klin (Munich); 2002 Aug; 97(8):455-8. PubMed ID: 12229244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark.
    Thybo S; Gjorup I; Ronn AM; Meyrowitsch D; Bygberg IC
    J Travel Med; 2004; 11(4):220-3. PubMed ID: 15541224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.
    Wichmann O; Muehlen M; Gruss H; Mockenhaupt FP; Suttorp N; Jelinek T
    Malar J; 2004 Jun; 3():14. PubMed ID: 15186499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
    Giao PT; De Vries PJ; Hung LQ; Binh TQ; Nam NV; Kager PA
    Ann Trop Med Parasitol; 2003 Sep; 97(6):575-80. PubMed ID: 14511555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children.
    Anabwani G; Canfield CJ; Hutchinson DB
    Pediatr Infect Dis J; 1999 May; 18(5):456-61. PubMed ID: 10353520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
    Färnert A; Lindberg J; Gil P; Swedberg G; Berqvist Y; Thapar MM; Lindegårdh N; Berezcky S; Björkman A
    BMJ; 2003 Mar; 326(7390):628-9. PubMed ID: 12649236
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
    Pimentel S; Nogueira F; Benchimol C; Quinhentos V; Bom J; Varandas L; do Rosário V; Bernardino L
    Malar J; 2006 Apr; 5():30. PubMed ID: 16597338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria.
    Sabchareon A; Attanath P; Phanuaksook P; Chanthavanich P; Poonpanich Y; Mookmanee D; Chongsuphajaisiddhi T; Sadler BM; Hussein Z; Canfield CJ; Hutchinson DB
    Trans R Soc Trop Med Hyg; 1998; 92(2):201-6. PubMed ID: 9764334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malarone-donation programme in Africa.
    Ringwald P; Basco LK
    Lancet; 1998 Feb; 351(9103):673-4. PubMed ID: 9500354
    [No Abstract]   [Full Text] [Related]  

  • 15. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
    Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
    [No Abstract]   [Full Text] [Related]  

  • 16. Atovaquone and proguanil for Plasmodium falciparum malaria.
    Radloff PD; Philipps J; Nkeyi M; Hutchinson D; Kremsner PG
    Lancet; 1996 Jun; 347(9014):1511-4. PubMed ID: 8684102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.
    Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.
    Shanks GD; Gordon DM; Klotz FW; Aleman GM; Oloo AJ; Sadie D; Scott TR
    Clin Infect Dis; 1998 Sep; 27(3):494-9. PubMed ID: 9770146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro.
    Edstein MD; Yeo AE; Kyle DE; Looareesuwan S; Wilairatana P; Rieckmann KH
    Trans R Soc Trop Med Hyg; 1996; 90(4):418-21. PubMed ID: 8882194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.